Children's Hospital Colorado

VALIANT (Apellis 310)

January 27, 2023
Diagnosis
Complement 3 Glomerulopathy(C3G) or Immune-complex mediated membranoproliferative glomerulonephritis (IC-MPGN)
Age
12 and up
COMIRB number
22-0644
Compensation
Yes

Overview

VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).

Contact us

For more information contact Kati.Dugan@childrenscolorado.org